Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
Connolly, Stuart J; Milling, Truman J; Eikelboom, John W; Gibson, C Michael; Curnutte, John T; Gold, Alex; Bronson, Michele D; Lu, Genmin; Conley, Pamela B; Verhamme, Peter; Schmidt, Jeannot; Middeldorp, Saskia; Cohen, Alexander T; Beyer-Westendorf, Jan; Albaladejo, Pierre; Lopez-Sendon, Jose; Goodman, Shelly; Leeds, Janet; Wiens, Brian L; Siegal, Deborah M; Zotova, Elena; Meeks, Brandi; Nakamya, Juliet; Lim, W Ting; Crowther, Mark.
N Engl J Med
; 375(12): 1131-41, 2016 09 22.
Artigo em Inglês | MEDLINE | ID: mdl-27573206
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysis.
[Effectiveness of Prothrombin Complex Concentrate for Warfarin-related Intracranial Hemorrhage].
[Factor Xa Inhibitor for the Treatment of Cerebral Venous Thrombosis with Intracerebral Hemorrhage during Anticoagulation Therapy:A Case Report].
Intracranial bleedings in patients on long-term anticoagulant treatment: Benefits from oral thrombin and factor Xa inhibitors in clinical practice.
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.
Anticoagulation-related intracranial hemorrhages.
Efficacy and safety of prothrombin complex concentrate for vitamin K antagonist-associated intracranial hemorrhage: a systematic review and meta-analysis.
Biosurgical Hemostatic Agents in Neurosurgical Intracranial Procedures.
Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.